Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Patent CN115043704A reveals a novel Rh-catalyzed kinetic resolution for high-purity gem-difluoro cyclopropane intermediates, offering significant supply chain and cost advantages.
Discover a novel preparation method for Ruxolitinib intermediates with >98% ee value. Optimize your supply chain with cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN1359887A details a novel resolution method for high-purity intermediates. Achieve significant cost reduction and supply chain reliability with scalable phthalate ester technology.
Patent CN117363683A reveals advanced enzymatic resolution for benzodiazepine-acetate. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101381387B reveals a stereoselective method for Gemcitabine HCl. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel method for (7S)-5-azaspiro[2.4]heptane-7-ylcarbamate tert-butyl ester. High optical purity, scalable process, cost-effective supply chain solutions for global pharma.
Patent CN1651430A reveals a robust Tiagabine synthesis route eliminating expensive organometallics. Discover cost-effective, scalable API intermediate manufacturing solutions.
Patent CN103694230A reveals amino acid eutectic purification for Canagliflozin. Achieve <0.5% alpha-impurity with scalable, cost-effective pharmaceutical intermediate solutions.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN103396429B reveals enzymatic synthesis of silicon chiral centers. Achieve >99% ee with mild conditions. Reliable supplier for cost reduction in fine chemical manufacturing.
Patent CN102391145B details a water-based recrystallization method for ubenimex intermediates, offering high purity and cost-effective manufacturing solutions.
Novel resolution method for dexmedetomidine hydrochloride ensures high purity and cost efficiency for pharmaceutical supply chains globally.
Patent CN105969836A details a lipase YCJ01 catalyzed process for high-purity vinelactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced anhydrous synthesis of Sulfobenicillin Sodium via patent CN108373475B. Delivers >99% purity and >90% yield for reliable pharmaceutical supply chains.
Patent CN1656230A reveals enzymatic resolution for high-purity glycol ethers. Discover cost-effective supply chain solutions and scalable manufacturing processes.
Novel enzymatic route for amino alcohol intermediates reduces waste and improves chirality. Reliable supply chain partner for scalable pharmaceutical manufacturing.
Novel lacosamide synthesis avoiding toxic reagents. High yield, scalable process for reliable API intermediate supply chain partners.
Novel chiral resolution patent CN103086877B enables high-purity pharmaceutical intermediates with reduced costs and scalable production for global supply chains.
Patent CN104711313A details enzymatic resolution for eldecalcitol intermediates. This method ensures high purity and cost reduction in pharmaceutical intermediate manufacturing.